Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

12.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.8K
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

1.5K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of Right-Handed D-Sulfonyl-γ-AApeptides with Broad-Spectrum Antimicrobial Activity.

Journal of medicinal chemistry·2026
Same author

α/Sulfonyl-γ-AApeptide foldamers mitigate Alzheimer's disease pathology by stabilizing transient helical domains in Aβ.

Nature communications·2026
Same author

The Progress of Active Immunotherapy for Parkinson's Disease.

International journal of molecular sciences·2026
Same author

Discovery of peptidomimetic inhibitors of CREB/CBP by targeting hydrophobic grooves on the surface of the CBP KIX domain.

Acta pharmaceutica Sinica. B·2026
Same author

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease.

Genome biology·2025
Same author

Recognition of the CREB-Binding Protein/Mixed Lineage Leukemia Interface by Sulfonyl-γ-AApeptides: Beyond Mimicry of Mixed Lineage Leukemia.

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Dec 17, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.9K

Dimeric γ-AApeptides With Potent and Selective Antibacterial Activity.

Minghui Wang1, Ruixuan Gao1, Peng Sang1

  • 1Department of Chemistry, University of South Florida, Tampa, FL, United States.

Frontiers in Chemistry
|June 30, 2020
PubMed
Summary

Novel dimeric gamma-AApeptide derivatives show promise as new antibiotics. Compound 2 effectively combats antibiotic-resistant bacteria like MRSA by disrupting cell membranes and inhibiting biofilms, offering a potential solution to the growing threat of antimicrobial resistance.

Keywords:
Gram-positive strainsantimicrobialdrug resistancehost defense peptideγ-AApeptides

More Related Videos

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.5K
Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

2.6K

Related Experiment Videos

Last Updated: Dec 17, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.9K
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.5K
Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

2.6K

Area of Science:

  • Medicinal Chemistry
  • Antimicrobial Research
  • Drug Discovery

Background:

  • Increasing prevalence of antibiotic resistance in bacteria poses a significant global health threat.
  • Urgent need for novel antimicrobial agents to combat drug-resistant pathogens.

Purpose of the Study:

  • To develop and evaluate novel dimeric gamma-AApeptide derivatives as potential antibiotic agents.
  • To assess the efficacy, toxicity, and resistance development potential of these compounds against Gram-positive bacteria.

Main Methods:

  • Synthesis of dimeric gamma-AApeptide derivatives.
  • Determination of Minimum Inhibitory Concentrations (MICs) against Gram-positive strains, including MRSA.
  • Evaluation of drug resistance development through serial passages.
  • Time-kill kinetics and mechanistic studies involving membrane disruption.
  • Assessment of biofilm inhibition.

Main Results:

  • Dimeric gamma-AApeptide derivatives demonstrated limited toxicity and high selectivity for Gram-positive bacteria.
  • Compound 2 exhibited potent antimicrobial activity (low MICs) and did not induce drug resistance after prolonged exposure to MRSA.
  • Compound 2 rapidly eradicated MRSA within 2 hours by mimicking host-defense peptides and disturbing bacterial membranes.
  • Effective inhibition of biofilm formation was observed even at low concentrations.

Conclusions:

  • Dimeric gamma-AApeptide derivatives represent a promising class of novel antibacterial agents.
  • Compound 2 shows significant potential for treating infections caused by antibiotic-resistant Gram-positive bacteria.
  • The mechanism of action involves bacterial membrane disruption and biofilm inhibition, suggesting broad applicability.